<p>The utilization of nanocarrier systems enables the targeted delivery of therapeutic drugs to specific tissues and organs through binding to the surfaces or cores of nanoparticles. The ability to sustain optimal drug levels within the body is contingent upon the controlled release of therapeutic medications. These substances have the capacity to enhance the bioavailability of poorly soluble drugs by increasing their solubility. Furthermore, they can protect sensitive therapeutic agents from degradation, thereby maintaining their effectiveness until they reach their target. A range of nanopharmaceutical systems, designed for various therapeutic applications, have undergone rigorous evaluation in preclinical and clinical studies, yielding encouraging results. This review examines the role of nanocarrier systems in enhancing the efficacy of pharmaceuticals used to treat various diseases. Finally, the challenges encountered in the production and application of nanocarriers, and future research opportunities are also presented.</p>